Hodgkin's lymphoma survivors may have increased risk for cardiovascular disease
the ONA take:
According to a new study published online in JAMA Internal Medicine, researchers in the Netherlands have found that survivors of Hodgkin's lymphoma may be at a higher risk for cardiovascular diseases.
For the study, researchers evaluated 2,524 Dutch patients diagnosed with Hodgkin's lymphoma at younger than 51 years of age who had survived for 5 years after diagnosis. Patients had received mediastinal radiotherapy and anthracycline-containing chemotherapy.
Results showed that Hodgkin's lymphoma survivors had a 4-fold to 7-fold increased risk for coronary heart disease or heart failure 35 years or more after cancer treatment compared with the general population.
Researchers also found that mediastinal radiotherapy increased the risk for coronary heart disease, valvular heart disease, and heart failure, while those who received anthracycline-containing chemotherapy had a higher risk for valvular heart disease and heart failure as first events events versus patients who did not receive those treatments.
The findings suggest that "treating physicians and patients should be aware of the persistently increased risk of cardiovascular diseases throughout life, and the results of our study may direct guidelines for follow-up of patients with HL."
Survivors of Hodgkin's lymphoma may be at a higher risk for cardiovascular diseases.
Sign Up for Free e-newsletters
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Modified XELIRI Noninferior to FOLFIRI for OS in Metastatic Colorectal Cancer
- Nabilone Improves Cancer-Associated Anorexia in Lung Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|